IPO GMP - Expect Returns of 30% to 113%, 6 Companies Open for Investment

INVESTMENT is a big question. Everyone has their own targets and risk levels. If you want to gain from IPO LISTING, you should study these 6 companies in the stock market. In the grey market, shares of these companies are being bought at a premium. As a result, the estimated listing price of the IPO has increased. This means that anyone who subscribes to the IPOs of these companies can expect returns ranging from 30% to 113%.

Rajputana Industries IPO GMP Trend

In the past year, the company's revenue has increased by 28.11% and Profit After Tax (PAT) has grown by 65.54%. On July 24, the IPO price had not opened, but in the grey market, it was bid at a ₹40 premium. On July 25, the IPO price opened at ₹38. The premium was still ₹40. On July 27, it started trading at a ₹43 premium, and today, when the IPO opened, it is still trading at a ₹43 premium. As a result, the estimated listing price has become ₹81. This means that anyone who subscribes to this IPO will get shares at a rate of ₹38, and on the listing day of August 6, the share price is expected to be ₹81, providing a return of 113.16% in just 7 days.

Sathlokhar Synergys E&C Global IPO GMP Trend

In the past year, the company's revenue has increased by 83.77% and Profit After Tax (PAT) has grown by 380.51%. For investors, this is a highly favorable situation. Everyone wants to invest in such a company, which is why in the grey market, it has been trading at a ₹90 premium since July 24. The company has announced the IPO price at ₹140. On July 29, just one day before the IPO opened, trading started at a ₹140 premium. As a result, the estimated listing price has become ₹280. If this situation continues until the listing day on August 6, those who subscribe to this company's IPO will gain a 100% return on their investment in just 7 days.

Bulkcorp IPO GMP Trend

When the company opened its IPO price at ₹105 on July 25, it started trading at just an ₹8 premium in the grey market. However, the company management has shown a revenue growth of 19.37% and Profit After Tax (PAT) growth of 193.6% in the past year. Therefore, on July 27, the premium amount increased from ₹8 to ₹85. As a result, the estimated listing price has become ₹190, giving IPO subscribers a chance to profit by 80.95%.

Akums Drugs and Pharmaceuticals IPO GMP Trend

This is a 20-year-old pharma company. In the past year, the company's revenue has increased by 13.81%, but Profit After Tax (PAT) has decreased by 99.19%. In FY 22-23, the company's PAT was around ₹99 crore, which decreased by 99% to ₹79 lakh in FY 23-24. After much calculation, the IPO price was opened at ₹679. Despite this, the company is receiving respect in the grey market. On July 25, when the IPO price opened, it started trading at a ₹165 premium, which increased to ₹211 by July 29. Today, when the IPO opened, it is trading at a ₹4 premium in the grey market. The estimated listing price has become ₹883, giving IPO subscribers a potential profit of 30.04%.

Disclaimer- This is merely news published to inform investors of the INDIAN SHARE MARKET. We do not encourage or discourage investment in any company. Please consult your FINANCIAL ADVISOR and invest in the stock market based on your study.